In conclusion, this study evaluates the impact of MUC16/CA125 expression and potential pathway alterations in patients with CCA on survival after resection in curative intent for all known histopathological subtypes in a large cohort and its potential role as a prognostic marker. This evidence concerns the gene MUC16 and cholangiocarcinoma.